You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Pediatric Pearls for Practice 

  • Authors: Peter A. Lio, MD; Lawrence F. Eichenfield, MD; Elaine Siegfried, MD; Jeffrey L. Sugarman, MD, PhD
  • CME / ABIM MOC / CE Released: 5/19/2022
  • Valid for credit through: 5/19/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.75 ABIM MOC points

    Nurses - 1.75 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians (PCPs), pediatricians, nurses, nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with various dermatologic conditions.

The goal of this activity is that learners will be better able to manage pediatric patients with dermatologic conditions.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Treatment strategies for individualized management of pediatric dermatologic conditions
    • Data on new and emerging treatments for molluscum contagiosum
  • Have greater competence related to
    • Selecting treatments that consider patient-related factors such as age, severity, Fitzpatrick skin type, and comorbid conditions
  • Demonstrate greater confidence in their ability to
    • Leverage treatment strategies for the individualized management of pediatric dermatologic conditions in a team-based setting


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Peter A. Lio, MD

    Clinical Assistant Professor of Dermatology and Pediatrics Northwestern University Feinberg School of Medicine
    Founding Director, Chicago Integrative Eczema Center
    Founding Partner, Medical Dermatology Associates of Chicago
    Chicago, Illinois

    Disclosures

    Disclosure: Peter A. Lio, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Almirall; Altus Labs; Amyris; AOBiome; Arbonne; ASLAN; Bodewell; Boston Skin Science; Burt's Bees; Castle Biosciences; Concerto; Dermavant; Exeltis; Galderma; IntraDerm; Janssen; Johnson & Johnson; Kaleido; Kimberly-Clark; KP Away; Level Ex; Lilly; Lipidor; L'Oreal; Menlo; Micreos; MyOR Diagnostics; Pierre Fabre; Pfizer; Realm; Regeneron; Sanofi; Theraplex; Unilever; Verrica; YobeeCare
    Speaker or member of speakers bureau for: AbbVie; Galderma; Incyte; Leo; L'Oreal; Pfizer; Regeneron; Sanofi
    Research funding from: AbbVie; AOBiome; Regeneron; Sanofi
    Contracted researcher for: AbbVie; AOBiome; Regeneron; Sanofi
    Royalties from: Theraplex
    Patent beneficiary of: Theraplex
    Stock options from: Altus; Boston Skin Science; Concerto; KP Away; Micreos; YobeeCare

  • Lawrence F. Eichenfield, MD

    Chief, Pediatric and Adolescent Dermatology
    Professor, Dermatology and Pediatrics
    Vice Chair, Department of Dermatology
    University of California
    San Diego School of Medicine
    Rady Children's Hospital
    San Diego, California

    Disclosures

    Disclosure: Lawrence F. Eichenfield, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Almirall; Arcutis; Arena; ASLAN; Castle Creek; Dermavant; Forté; Galderma; Glenmark; Ichnos; Incyte; Krystal Bio; Leo; Lilly; Novartis; Ortho; Otsuka; Pfizer; Regeneron; Sanofi; Verrica
    Speaker or member of speakers bureau for: Incyte; Krystal Bio; Leo; Novartis; Regeneron; Sanofi
    Research funding from: AbbVie; Bausch; Galderma; Pfizer
    Stock options from: Forté; Verrica
    Monetary compensation for an executive role from: Forté; Verrica

  • Elaine Siegfried, MD

    Director of Pediatric Dermatology
    SSM Cardinal Glennon
    Children's Medical Center
    Professor of Pediatrics and Dermatology
    Saint Louis University School of Medicine
    St Louis, Missouri

    Disclosures

    Disclosure: Elaine Siegfried, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; ASLAN; Boehringer Ingelheim; Incyte; Leo; Novan; Novartis; Pfizer; Pierre Fabre; Regeneron; Sanofi; UCB; Verrica
    Speaker or member of speakers bureau for: Regeneron; Sanofi; Verrica
    Research funding from: Janssen; Lilly; Pierre Fabre; Regeneron; Verrica
    Other: DSMB: Leo; Novan; Pfizer; UCB

  • Jeffrey L. Sugarman, MD, PhD

    Professor in Dermatology
    University of California San Francisco
    San Francisco, California

    Disclosures

    Disclosure: Jeffrey L. Sugarman, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Bausch; Galderma; Novartis; Pfizer; Regeneron; Solgel
    Speaker or member of speakers bureau for: Novartis; Pfizer; Regeneron; Sanofi

Editors

  • Meghan Coulehan, MPH

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    Disclosure: Meghan Coulehan, MPH, has no relevant financial relationships.

  • Roderick Smith, MS

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Roderick Smith, MS, has no relevant financial relationships.

Compliance Reviewer

  • Esther Nyarko, PharmD

    Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has no relevant financial relationships.

Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Pediatric Pearls for Practice 

Authors: Peter A. Lio, MD; Lawrence F. Eichenfield, MD; Elaine Siegfried, MD; Jeffrey L. Sugarman, MD, PhDFaculty and Disclosures

CME / ABIM MOC / CE Released: 5/19/2022

Valid for credit through: 5/19/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Quick Check: Advances in Pediatric Atopic Dermatitis

Redefining the pediatric AD landscape
Elaine Siegfried, MD

Quick Check: Pediatric Acne Best Practices

Familiarize yourself with the ever-expanding list of AD resources!
Lawrence F. Eichenfield, MD

Psoriasis in Pediatric Patients

Optimize your approach to pediatric psoriatic care
Elaine Siegfried, MD

Pediatric Rashes

Spotting the telltale signs and symptoms
Lawrence F. Eichenfield, MD

Expert Insights in the Treatment of Warts and Molluscum Contagiosum

Practical guidance on notorious conditions
Peter A. Lio, MD

Making Sense of Rare Genetic Dermatologic Disorders

Understanding the complexity surrounding rare disease states
Jeffrey L. Sugarman, MD, PhD
 

Educational Impact Challenge

The goal of this activity is that learners will be better able to manage pediatric patients with dermatologic conditions.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print